These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 28429542)
1. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT). Barsheshet A; Kutyifa V; Vamvouris T; Moss AJ; Biton Y; Chen L; Storozynsky E; Wan C; Szymkiewicz SJ; Goldenberg I J Cardiovasc Electrophysiol; 2017 Jul; 28(7):778-784. PubMed ID: 28429542 [TBL] [Abstract][Full Text] [Related]
2. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting. Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442 [TBL] [Abstract][Full Text] [Related]
3. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618 [TBL] [Abstract][Full Text] [Related]
4. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients. Erath JW; Vamos M; Sirat AS; Hohnloser SH Clin Res Cardiol; 2017 Apr; 106(4):300-306. PubMed ID: 27888304 [TBL] [Abstract][Full Text] [Related]
5. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study. Duncker D; König T; Hohmann S; Bauersachs J; Veltmann C J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096098 [TBL] [Abstract][Full Text] [Related]
6. Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry. Veltmann C; Winter S; Duncker D; Jungbauer CG; Wäßnig NK; Geller JC; Erath JW; Goeing O; Perings C; Ulbrich M; Roser M; Husser D; Gansera LS; Soezener K; Malur FM; Block M; Fetsch T; Kutyifa V; Klein HU Clin Res Cardiol; 2021 Jan; 110(1):102-113. PubMed ID: 32377784 [TBL] [Abstract][Full Text] [Related]
7. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD. Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177 [TBL] [Abstract][Full Text] [Related]
8. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518 [TBL] [Abstract][Full Text] [Related]
9. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator. Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055 [TBL] [Abstract][Full Text] [Related]
10. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
11. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland. Kovacs B; Reek S; Saguner AM; Krasniqi N; Eriksson U; Duru F Swiss Med Wkly; 2019 Nov; 149():w20136. PubMed ID: 31707723 [TBL] [Abstract][Full Text] [Related]
12. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator. Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779 [TBL] [Abstract][Full Text] [Related]
13. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Duncker D; Haghikia A; König T; Hohmann S; Gutleben KJ; Westenfeld R; Oswald H; Klein H; Bauersachs J; Hilfiker-Kleiner D; Veltmann C Eur J Heart Fail; 2014 Dec; 16(12):1331-6. PubMed ID: 25371320 [TBL] [Abstract][Full Text] [Related]
14. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis. Opreanu M; Wan C; Singh V; Salehi N; Ahmad J; Szymkiewicz SJ; Thakur RK J Heart Lung Transplant; 2015 Oct; 34(10):1305-9. PubMed ID: 26094085 [TBL] [Abstract][Full Text] [Related]
15. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital. Sinha AM; Bense J; Hohenforst-Schmidt W J Interv Card Electrophysiol; 2021 Nov; 62(2):401-407. PubMed ID: 33200285 [TBL] [Abstract][Full Text] [Related]
16. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator. Goldenberg I; Erath JW; Russo AM; Burch AE; Assmus B; Bonderman D; McNitt S; Kutyifa V Heart Rhythm; 2021 Mar; 18(3):404-410. PubMed ID: 33248269 [TBL] [Abstract][Full Text] [Related]
17. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Klein HU; Meltendorf U; Reek S; Smid J; Kuss S; Cygankiewicz I; Jons C; Szymkiewicz S; Buhtz F; Wollbrueck A; Zareba W; Moss AJ Pacing Clin Electrophysiol; 2010 Mar; 33(3):353-67. PubMed ID: 19889186 [TBL] [Abstract][Full Text] [Related]
18. Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report. Andresen H; Sasko B; Patschan D; Pagonas N; Ritter O J Med Case Rep; 2021 May; 15(1):243. PubMed ID: 33993888 [TBL] [Abstract][Full Text] [Related]
19. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death. Kutyifa V; Vermilye K; Daimee UA; McNitt S; Klein H; Moss AJ Europace; 2018 Sep; 20(FI2):f225-f232. PubMed ID: 29905788 [TBL] [Abstract][Full Text] [Related]
20. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]